Company: FCRX
Filing Date: 2025-02-03
Form Type: N-2/A
Source: 0001193125-25-018583
Chunk: 91

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-03
Form: N-2/A
Chunk 91
---
 In making a determination that an offering of common stock below its net asset value per share is in our and our stockholders’ best interests, our Board will consider a variety of factors including:

| • |     | the effect that an offering below net asset value per share would have on our stockholders, including the potential dilution to the net asset value per share of our common stock our stockholders would experience as a result of the offering; |

| • |     | the amount per share by which the offering price per share and the net proceeds per share are less than our most recently determined net asset value per share; |

| • |     | the relationship of recent market prices of par common stock to net asset value per share and the potential impact of the offering on the market price per share of our common stock; |

| • |     | whether the estimated offering price would closely approximate the market value of shares of our common stock; |

| • |     | the potential market impact of being able to raise capital during the current financial market difficulties; |

| • |     | the nature of any new investors anticipated to acquire shares of our common stock in the offering; |

| • |     | the anticipated rate of return on and quality, type and availability of investments; and |

| • |     | the leverage available to us. |

Our Board will also consider the fact that sales of shares of common stock at a discount will benefit our investment advisor as our investment advisor will earn additional investment management fees on the proceeds of such offerings, as it would from the offering of any other of our securities or from the offering of common stock at premium to net asset value per share. We will not sell shares of our common stock pursuant to stockholder approval (or any rights, warrants or units to purchase shares of our common stock) under this prospectus or an accompanying prospectus supplement without first filing a new post effective amendment to the registration statement if the cumulative dilution to our net asset value per share from offerings under the registration statement, as amended by such post effective amendment, exceeds 15%. This would be measured separately for each offering pursuant to the registration statement, as amended by this post effective amendment, by calculating the percentage dilution or accretion to aggregate net asset value from that offering and then summing the percentage from each offering. For example, if our most recently determined net asset value per share at the time of the first offering is $10.00 and we have 1,000,000 shares of common stock outstanding, the